taxifolin has been researched along with Diabetes Mellitus, Type 2 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, S; Rawat, RS | 1 |
| Ahmed, SA; Barge, SR; Bharadwaj, S; Borah, JC; Gurumayum, S; Saikia, K; Sheikh, Y; Swargiary, D; Thakur, D | 1 |
| Ihara, M; Iwasa, M; Iwashita, K; Kato, H; Kato, S; Kawamoto, A; Nishimura, H; Saito, S; Satoh-Asahara, N; Suganami, T; Tanaka, M; Yamakage, H | 1 |
| Akash, MSH; Chohan, TA; Gilani, Z; Rehman, K; Waheed, I | 1 |
| Alisievich, SV; Fedosova, NF; Kubatiev, AA; Lyadov, KV; Romanova, EP; Rudko, IA | 1 |
5 other study(ies) available for taxifolin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Understanding the mode of inhibition and molecular interaction of taxifolin with human adenosine deaminase.
Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Diabetes Mellitus, Type 2; Humans; Pentostatin | 2023 |
Taxifolin-3-O-glucoside from Osbeckia nepalensis Hook. mediates antihyperglycemic activity in CC1 hepatocytes and in diabetic Wistar rats via regulating AMPK/G6Pase/PEPCK signaling axis.
Topics: AMP-Activated Protein Kinases; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Glucose; Glucosides; Hepatocytes; Hypoglycemic Agents; Liver; Molecular Docking Simulation; Rats; Rats, Wistar | 2023 |
Taxifolin Suppresses Inflammatory Responses of High-Glucose-Stimulated Mouse Microglia by Attenuating the TXNIP-NLRP3 Axis.
Topics: Animals; Diabetes Mellitus, Type 2; Glucose; Inflammasomes; Interleukin-1beta; Mice; Microglia; Neuroinflammatory Diseases; NLR Family, Pyrin Domain-Containing 3 Protein; Reactive Oxygen Species | 2023 |
Taxifolin prevents postprandial hyperglycemia by regulating the activity of α-amylase: Evidence from an in vivo and in silico studies.
Topics: Acarbose; Alloxan; alpha-Amylases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Blood Glucose; C-Reactive Protein; Catalytic Domain; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glycoside Hydrolase Inhibitors; Lipase; Lipid Metabolism; Male; Molecular Docking Simulation; Molecular Dynamics Simulation; Quercetin; Rats | 2019 |
Mechanisms underlying diquertin-mediated regulation of neutrophil function in patients with non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Antioxidants; Case-Control Studies; Diabetes Mellitus, Type 2; Humans; Hypochlorous Acid; In Vitro Techniques; Lipid Peroxidation; Male; Middle Aged; Neutrophils; Quercetin; Superoxides | 2004 |